PACB (Pacific Biosciences of California) Cyclically Adjusted Book per Share: $0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PACB Pacific Biosciences of California Inc PACB
55 GF Score
Price $1.19
GF Value $1.48
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Cyclically Adjusted Book per Share?

Pacific Biosciences of California PACB +1.72% 55 Cyclically Adjusted Book per Share is $0.00 as of Jun. 2026. GuruFocus rates PACB with a GF Score™ of 55/100 and a GF Value™ of $1.48 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pacific Biosciences of California's adjusted book value per share for the three months ended in Jun. 2026 was $-0.107. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Pacific Biosciences of California's average Cyclically Adjusted Book Growth Rate was -2.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pacific Biosciences of California was 7.50% per year. The lowest was -2.30% per year. And the median was 3.15% per year.

As of today (2026-08-08), Pacific Biosciences of California's current stock price is $1.185. Pacific Biosciences of California's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $0.00. Pacific Biosciences of California's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pacific Biosciences of California was 34.00. The lowest was 0.56. And the median was 4.02.


Pacific Biosciences of California  (NAS:PACB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pacific Biosciences of California was 34.00. The lowest was 0.56. And the median was 4.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pacific Biosciences of California Cyclically Adjusted Book per Share Related Terms


Pacific Biosciences of California Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Cyclically Adjusted Book per Share Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 1.39 1.53 1.65 1.62

Pacific Biosciences of California Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.66 1.66 1.62 1.62 0.00

PACB vs DCTH, CLPT, SI: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Pacific Biosciences of California's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Cyclically Adjusted PB Ratio falls into.


PACB
55GF Score
Pacific Biosciences of California Inc PACB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacific Biosciences of California's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.107/333.9520*333.9520
=-0.107

Current CPI (Jun. 2026) = 333.9520.

Pacific Biosciences of California Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.066 241.428 1.475
201612 0.914 241.432 1.264
201703 0.740 243.801 1.014
201706 1.003 244.955 1.367
201709 0.872 246.819 1.180
201712 0.740 246.524 1.002
201803 0.779 249.554 1.042
201806 0.648 251.989 0.859
201809 0.886 252.439 1.172
201812 0.759 251.233 1.009
201903 0.621 254.202 0.816
201906 0.495 256.143 0.645
201909 0.333 256.759 0.433
201912 0.359 256.974 0.467
202003 0.392 258.115 0.507
202006 0.268 257.797 0.347
202009 0.720 260.280 0.924
202012 1.745 260.474 2.237
202103 1.415 264.877 1.784
202106 1.298 271.696 1.595
202109 3.812 274.310 4.641
202112 3.579 278.802 4.287
202203 3.275 287.504 3.804
202206 3.034 296.311 3.419
202209 2.774 296.808 3.121
202212 2.485 296.797 2.796
202303 2.771 301.836 3.066
202306 2.563 305.109 2.805
202309 2.956 307.789 3.207
202312 2.619 306.746 2.851
202403 2.384 312.332 2.549
202406 1.808 314.175 1.922
202409 1.655 315.301 1.753
202412 1.721 315.605 1.821
202503 0.305 319.799 0.318
202506 0.205 322.561 0.212
202509 0.120 324.800 0.123
202512 0.018 324.054 0.019
202603 0.008 330.213 0.008
202606 -0.107 333.952 -0.107

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
Pacific Biosciences of California (PACB) has a Cyclically Adjusted Book per Share of $0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's Cyclically Adjusted Book per Share too high?
Pacific Biosciences of California's current Cyclically Adjusted Book per Share is $0.00. Overall, Pacific Biosciences of California has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Cyclically Adjusted Book per Share compare to DCTH and CLPT?
Pacific Biosciences of California's Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Based on GuruFocus' analysis, Pacific Biosciences of California (PACB) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.48, compared to a current price of $1.19 — trading 19.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is $0.00. Pacific Biosciences of California's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pacific Biosciences of California (PACB), the current Cyclically Adjusted Book per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued. The current stock price of $1.19 is trading 19.9% below its estimated GF Value™ of $1.48. GuruFocus considers Pacific Biosciences of California to be Modestly Undervalued.

Key valuation signals for PACB:

  • Cyclically Adjusted Book per Share: $0.00
  • GF Value™: $1.48 vs. price of $1.19 (19.9% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pacific Biosciences of California Business Description

Other Exchanges P09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
55GF Score

Get the complete analysis for PACB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$1.48
GF Value